Home › Kanser sa Pancreas › New Mexico
Pag-aaral pangklinika para sa Kanser sa Pancreas sa New Mexico
6 pag-aaral para sa Kanser sa Pancreas ang naghahanap ng mga kalahok sa mga site sa New Mexico.
Mga Lungsod sa New Mexico
Opisyal na teksto ng pag-aaral (English)
DESTINY-PANTUMOUR04
- Research Site, Farmington
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- University of New Mexico Cancer Center, Albuquerque
Nagre-recruitObservasyonal na pag-aaral
Edad 50 hanggang 75 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT04239573A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.
- Christus St. Vincent Regional Cancer Center, Santa Fe
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07157033A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Albuquerque
- Ohio State University Telemedicine, Roswell
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 17, 2026 · NCT06906562VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Presbyterian Kaseman Hospital (site 208), Albuquerque
Nagre-recruitPhase 1/2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Dis 11, 2025 · NCT03556228SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Albuquerque
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.